Heron Therapeuti (HRTX) is a biotechnology company listed on US.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Use this HRTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HRTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HRTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Heron Therapeuti even when a live quote feed is slow.
Latest cached year on this hub. Full HRTX income, balance, and cash tables.